gener
reduc
equival
nadph
via
dehydrogenas
critic
mainten
redox
homeostasi
reduct
biosynthesi
cell
nadph
also
play
key
role
cellular
process
mediat
redox
signal
insuffici
activ
predispos
cell
growth
retard
demis
sever
lack
impair
embryon
develop
delay
organism
growth
alter
activ
associ
pathophysiolog
autophagi
insulin
resist
infect
inflamm
well
diabet
hypertens
aberr
activ
lead
enhanc
cell
prolifer
adapt
mani
type
cancer
present
review
aim
updat
exist
knowledg
concern
emphas
modul
redox
signal
affect
cell
surviv
demis
particularli
diseas
cancer
exploit
potenti
drug
target
cancer
also
discuss
human
granulocyt
exhibit
impair
hydrogen
peroxid
superoxid
product
similar
find
cell
lower
superoxid
releas
reduc
atherosclerot
lesion
observ
mice
crossbr
apo
null
hemizyg
mice
nadph
respons
superoxid
product
found
pacinginduc
heart
failur
canin
model
ventricular
tissu
homogen
show
increas
nadph
superoxid
activ
treatment
nox
inhibitor
dstat
inhibitor
significantli
reduc
superoxid
gener
fail
heart
homogen
upregul
myocardi
provid
suffici
nadph
fuel
superoxideproduc
enzym
suggest
redox
role
pathogenesi
heart
diseas
regul
nuclear
superoxid
product
cooper
hepatocyt
coloc
nucleu
close
relationship
maintain
ro
homeostasi
promot
downstream
redox
signal
includ
csrc
melanoma
cell
overexpress
bovin
aortic
endotheli
cell
baec
diminish
ro
accumul
follow
exposur
hydrogen
peroxid
xanthin
oxidas
upregul
baec
maintain
reduc
form
glutathion
gener
stimul
cytokin
donor
affect
cell
surviv
immun
respons
insulin
signal
stress
disord
provid
vascular
neural
protect
product
depend
statu
increas
level
found
saliva
refuge
suffer
stress
anxieti
upon
lipopolysaccharid
lp
pma
stimul
human
granulocyt
produc
nitrit
deriv
human
granulocyt
lack
fail
gener
presenc
lp
pma
cytokin
enhanc
induc
nitric
oxid
synthas
ino
express
product
pancreat
islet
cell
caus
cell
death
disrupt
insulin
secret
upregul
activ
reduc
cyclic
adenosin
monophosph
camp
level
activ
campdepend
protein
kinas
increas
activ
protein
kinas
pka
inhibitor
decreas
activ
statu
posit
correl
product
suppress
biochem
inhibitor
dehydroepiandrosteron
dhea
antisens
oligonucleotid
reduc
level
indic
campdepend
pka
enhanc
statu
stimul
sodium
nitroprussid
donor
stimul
cell
growth
fibroblast
induc
apoptosi
fibroblast
treatment
trolox
antioxid
ectop
express
revers
noinduc
apoptosi
fibroblast
suggest
prosurviv
role
reduc
activ
endotheli
cell
associ
elev
ro
decreas
bioavail
overexpress
baec
treat
bradykinin
also
enhanc
cgmp
no
activ
result
increas
bioavail
avail
essenti
regul
leukocyt
adhes
endothelium
endotheli
cell
display
lower
level
endotheli
nitric
oxid
synthas
eno
glutathion
gsh
treatment
endotheli
cell
high
concentr
glucos
proatherosclerot
stimulu
upregul
well
oxid
marker
ro
ino
contrast
lcystein
gsh
precursor
attenu
oxid
marker
suggest
gsh
play
role
endotheli
cell
protect
associ
avail
lp
increas
mrna
express
glucos
util
ppp
independ
ino
cultur
rat
astrocyt
inhibit
block
express
ino
inhibit
rat
astrocyt
dhea
prevent
ppp
activ
lower
cell
nadph
gsh
glutathion
disulfid
gssg
ratio
alter
gshgssg
ratio
due
dhea
revers
ino
inhibitor
amt
observ
indic
protect
astrocyt
nomedi
cell
damag
peroxynitrit
noderiv
neurotoxin
rapidli
increas
activ
ppp
neuron
astrocyt
primari
cultur
lead
increas
nadph
caus
glutathion
oxid
nadph
consumpt
apoptosi
neuron
astrocyt
peroxynitrit
treatment
counteract
effect
caus
neuron
endogen
exogen
peroxynitrit
induc
activ
cell
overexpress
confer
resist
nomedi
apoptosi
knockdown
exacerb
cellular
injuri
taken
togeth
crosstalk
crucial
cell
protect
h
endogen
gasotransmitt
involv
mani
biolog
function
includ
neuron
regul
smooth
muscl
relax
vascular
relax
blood
pressur
regul
inflamm
cell
death
signal
metabol
overstimul
receptor
isoproterenol
hypertroph
cardiomyocyt
rapidli
reduc
endogen
h
level
treatment
h
agonist
nah
norepinephrin
augment
h
product
suppress
hypertrophi
stimul
cardiomyocyt
rat
transvers
aortic
constrict
approxim
half
h
level
compar
normal
rat
treatment
nah
enhanc
activ
inhibitor
dhea
decreas
hypertroph
respons
cardiomyocyt
upregul
express
activ
rat
reduc
cardiac
neg
regul
prevent
dimer
inhibitor
either
dhea
revers
effect
rat
cardiac
hypertrophi
enhanc
activ
directli
inhibit
activ
indic
play
critic
role
mediat
cardiac
function
regul
h
global
transcriptom
analysi
reveal
h
modul
integr
metabol
network
regul
cellular
redox
homeostasi
consist
find
sever
common
biolog
process
emerg
transcriptom
data
show
critic
node
modul
effect
among
metabol
process
downstream
h
carbon
monoxid
co
also
gaseou
signal
molecul
produc
human
major
role
co
modul
cardiovascular
system
inhibit
platelet
aggreg
adhes
neuron
develop
like
h
co
antiapoptot
antiinflammatori
vasodilatori
also
promot
vascular
growth
abnorm
metabol
co
associ
diseas
includ
heart
failur
hypertens
inflamm
neurodegener
sinc
co
produc
hemoglobin
heme
oxygenas
use
index
heme
catabol
endogen
co
increas
neonat
hyperbilirubinemia
co
may
role
promot
neuron
differenti
coreleas
molecul
enhanc
neuron
differenti
neuroblastoma
ppp
pathway
neuroblastoma
upregul
co
includ
dehydrogenas
pgdh
oxid
branch
ppp
transketolas
tkt
nonoxid
branch
ppp
concentr
activ
also
increas
knockdown
revers
effect
neuron
differenti
induc
co
find
indic
protect
role
modul
coinduc
neuron
develop
alter
statu
implic
mani
cellular
pathophysiolog
process
diseas
includ
hypoxia
inflamm
microbi
infect
sepsi
pulmonari
vessel
dilat
diabet
hypertens
kidney
diseas
brain
injuri
ppp
glutathioneassoci
metabol
pathway
major
antioxid
defens
system
cell
regul
enzym
profoundli
affect
develop
clinic
outcom
diseas
one
proinflammatori
condit
lead
vascular
injuri
hyperglycemia
proinflammatori
cytokin
prime
high
glucoseinduc
vascular
inflamm
human
aortic
smooth
muscl
cell
hasmc
surplu
glucos
uptak
activ
central
role
dehydrogenas
product
ribos
reduc
equival
nicotinamid
adenin
dinucleotid
phosphat
nadph
via
pentos
phosphat
pathway
ppp
product
vital
synthesi
mani
biolog
build
block
nucleic
fatti
acid
long
known
nadph
extrem
import
mainten
antioxid
defens
preponder
evid
emerg
recent
indic
nadph
also
serv
prooxid
gener
reactiv
oxygen
speci
ro
reactiv
nitrogen
speci
rn
signal
molecul
promot
cellular
process
cell
growth
clinic
defici
pervas
xlink
enzymopathi
world
individu
tend
suffer
red
cell
disord
includ
jaundic
drugor
infectioninduc
hemolyt
anemia
disord
mostli
due
point
mutat
sever
defici
intoler
growth
develop
anim
model
modest
increas
promot
healthi
lifespan
mani
excel
review
discuss
prosurviv
role
part
ppp
affect
cell
includ
cancer
cell
growth
death
clearli
defin
enhanc
tumor
growth
maintain
intracellular
redox
homeostasi
activ
increas
sever
type
cancer
includ
bladder
breast
endometri
esophag
prostat
gastric
renal
hepat
colorect
cervic
lung
ovarian
cancer
glioblastoma
leukemia
well
glioma
current
review
provid
updat
exist
knowledg
concern
focus
involv
redox
signal
affect
cell
surviv
death
particularli
diseas
cancer
exploit
potenti
drug
target
cancer
also
discuss
product
superoxid
nadph
oxidas
nox
nitric
oxid
synthas
no
nadphdepend
ppp
major
pathway
nadph
gener
oxid
stress
consid
risk
factor
age
chronic
diseas
low
molecular
weight
signal
molecul
play
import
role
human
health
diseas
highli
reactiv
easili
diffus
molecul
includ
ro
rn
reactiv
sulfur
speci
rss
carbon
monoxid
ammonia
methan
question
whether
statu
affect
product
ro
rn
rss
regul
downstream
redox
signal
pathway
well
impact
human
health
diseas
great
interest
intracellular
rs
product
regul
enzymat
reaction
subsequ
affect
function
structur
protein
well
transcript
gene
modif
cystein
howev
excess
rs
also
contribut
develop
chronic
diseas
attack
cellular
compon
protein
lipid
nucleic
acid
lead
cellular
dysfunct
radic
well
effector
messeng
interact
ro
gener
rn
ro
rn
react
cystein
thiol
form
rss
hydrogen
sulfid
h
initi
consid
environment
toxin
inhibit
mitochondri
respir
endogen
h
play
role
divers
biochem
pathway
govern
signal
transduct
bioenerget
lifespan
bacteri
h
consid
protect
factor
confer
antibiot
resist
involv
host
immun
respons
inhal
h
mice
caus
hibernationlik
behavior
associ
reduc
bodi
temperatur
metabol
due
complex
interact
signal
molecul
downstream
effector
reactiv
speci
interactom
rsi
introduc
integr
concept
delin
complex
multipl
level
redox
regul
system
respons
variou
stress
environment
cue
rsi
increas
fit
flexibl
cell
tissu
organism
level
rapid
sens
adjust
full
understand
mechanist
action
rsi
open
opportun
appreci
redox
biolog
human
health
diseas
well
provid
novel
strategi
prevent
intervent
precis
medicin
upregul
glucos
transport
downregul
mitochondri
respir
alon
insuffici
stimul
inflammatori
respons
activ
ppp
excess
glucos
rerout
pathway
turn
overactiv
nox
produc
superoxid
reaction
neighbor
molecul
result
product
free
radic
stimul
downstream
inflammatori
signal
pathway
lead
endotheli
dysfunct
chronic
inflamm
adipos
tissu
implic
insulin
resist
found
obes
downregul
dehydrogenas
glutathionestransferas
gst
found
liver
age
streptozotocininduc
diabet
rat
antioxid
increas
activ
gst
diabet
rat
also
enhanc
activ
lung
heart
age
diabet
rat
find
suggest
diabetesinduc
glucotox
affect
modul
activ
redox
enzym
diabet
condit
impair
bodi
abil
process
blood
glucos
includ
type
type
gestat
diabet
defici
could
risk
factor
diabet
impair
activ
high
glucos
concentr
endotheli
kidney
cell
associ
increas
ro
product
decreas
cell
surviv
decreas
express
activ
induc
ubiquitin
increas
ro
podocyt
occur
high
glucos
concentr
hyperglycemia
obes
mice
result
increas
oxid
stress
vascular
endotheli
cell
caus
cardiovascular
complic
smaller
islet
impair
glucos
toler
observ
mice
abnorm
statu
mediat
insulin
resist
oxid
stress
adipos
tissu
found
obes
mice
upregul
occur
pancreat
diabet
murin
model
bone
marrow
transplant
mice
wildtyp
mice
reduc
obesityinduc
inflamm
adipos
tissu
improv
insulin
resist
overexpress
enhanc
ro
product
prooxid
enzym
includ
ino
nox
ro
accumul
apoptosi
indic
develop
type
diabet
highfatdiet
hfd
induc
obes
mice
decreas
insulin
homeostat
model
assess
insulin
resist
homair
index
mice
exhibit
glucos
insulin
toler
well
reduc
insulin
signal
suggest
defici
associ
improv
insulin
resist
downregul
nox
upregul
antioxid
gene
includ
catalas
glutathion
peroxidas
gpx
observ
mice
although
hfdinduc
adipos
fatti
liver
allevi
proinflammatori
macrophag
cytokin
reduc
mice
macrophag
decreas
phosphoryl
mapk
nuclear
transloc
proinflammatori
cytokin
ro
accumul
event
lead
enhanc
insulin
sensit
adipocyt
hepatocyt
aberr
statu
lipidoverload
hepatocyt
associ
impair
proinflammatori
cytokin
via
oxid
stress
howev
diseas
highli
inflammasom
activ
system
lupu
erythematosu
upregul
array
data
microbi
infect
patient
mainli
relat
hemolyt
anemia
caus
plasmodia
virus
lack
activ
risk
factor
neonat
sepsi
male
sepsisinduc
system
inflamm
direct
pulmonari
injuri
caus
acut
lung
injuri
ali
airway
epitheli
cell
aec
ali
induc
activ
concomit
increas
ro
nitrotyrosin
inhibitor
suppress
airway
inflamm
aec
induc
lp
ro
deriv
well
increas
glutathion
reductas
activ
lung
carcinoma
cell
sensit
staphylococc
infect
lead
apoptosi
ro
accumul
cell
suscept
corona
viru
infect
inflamm
signal
monocyt
sensit
infect
dengu
viru
redox
imbal
compar
match
control
monocyt
highli
express
human
liver
infect
hepat
b
viru
hbv
hbvassoci
cancer
activ
stimul
hepat
b
viru
x
protein
hbx
mediat
activ
transcript
factor
low
activ
children
follow
acut
hepat
infect
may
caus
high
morbid
mild
hepat
encephalopathi
mhe
hallmark
chronic
liver
failur
clf
upregul
nno
mhe
suggest
role
pathogenesi
increas
level
nno
associ
increas
activ
nadph
diaphoras
cerebellum
clf
rat
overactiv
observ
nadph
oxid
regul
vascular
muscl
relax
dimer
form
protein
kinas
g
induc
thiol
oxid
contribut
relax
isol
endotheliumremov
bovin
pulmonari
arteri
bpa
peroxid
respons
hypoxia
inhibitor
epiandrosteron
associ
enhanc
sirna
increas
dimer
bpa
henc
reduc
activ
associ
vasodil
may
benefici
amelior
pulmonari
hypertens
addit
hypoxia
activ
caus
prolifer
pulmonari
arteri
smooth
muscl
pasm
cell
increas
hypoxiainduc
factor
synthes
less
contractil
myocardin
prolif
cyclin
phosphohiston
protein
consequ
overactiv
contribut
remodel
pulmonari
arteri
develop
pulmonari
hypertens
archetyp
housekeep
enzym
maintain
growth
develop
diminish
activ
dysfunct
ppp
prevent
normal
cell
prolifer
well
embryon
organism
develop
aberr
activ
ppp
associ
tumorigenesi
rapidli
grow
cancer
cell
evolv
myriad
mechan
activ
support
cellular
requir
nadph
product
fatti
acid
nucleic
acid
synthesi
exampl
activ
prooncogen
pathway
enhanc
activ
includ
ra
src
naddepend
deacetylas
sirtuin
encod
gene
promot
nadph
product
leukemia
cell
growth
deacetyl
heat
shock
protein
enhanc
bind
lead
deacetyl
activ
activ
sustain
cellular
nadph
pentos
product
glioma
cell
desuccinyl
deglutaryl
isocitr
dehydrogenas
respect
thu
activ
nadphproduc
enzym
confer
resist
oxid
stress
signal
pathway
govern
cancer
cell
surviv
associ
statu
discuss
review
includ
signal
transduc
activ
transcript
stat
ampactiv
protein
kinas
ampk
kinas
pak
well
other
list
tabl
tabl
effect
upregul
dehydrogenas
cell
breast
enhanc
prolifer
migrat
upregul
prolifer
via
regul
emt
migrat
increas
glucos
uptak
nadph
product
histon
deacetylas
inhibitor
reprogram
metabol
upregul
elev
nadph
reduc
ro
overexpress
histon
methyltransferas
methyl
promot
upregul
hexokinas
reduc
cell
prolifer
target
utr
inhibit
prolifer
promot
apoptosi
reduc
xenograft
tumor
growth
nude
mice
suppress
activ
colon
high
nadp
inhibit
dihydrofol
reductas
dhfr
impair
folatemedi
biosynthesi
induc
compens
colorect
decreas
synthesi
ribos
nadph
acetyl
catalyt
site
aspirin
hepatocellular
suppress
ppp
flux
dna
synthesi
cell
growth
associ
athanogen
suppress
dimer
activ
reduc
activ
repress
express
signal
transduc
activ
transcript
stat
protein
transcript
factor
involv
immun
cellular
prolifer
apoptosi
differenti
misregul
stat
caus
cellular
transform
tumorigenesi
compromis
immun
surveil
stat
protein
constitut
activ
enhanc
express
prosurviv
progrowth
gene
although
directli
contribut
regul
dna
repair
cell
cycl
checkpoint
facilit
oncogenesi
close
relationship
apoptosi
angiogenesi
growth
factor
signal
pathway
melanoma
cell
highli
activ
knockdown
melanoma
cell
line
lead
reduct
phosphoryl
overexpress
human
melanoma
cell
enhanc
phosphoryl
likewis
phosphoryl
modul
statu
find
indic
import
role
oncogenesi
mediat
howev
detail
mechan
statu
activ
remain
unclear
use
melanoma
cell
line
xenograft
nude
mous
model
mice
inject
wildtyp
cell
display
faster
tumor
format
larger
tumor
size
mice
cell
tumor
wildtyp
cell
aggress
malign
compar
cell
observ
suggest
statu
vital
melanoma
prolifer
differenti
statu
melanoma
cell
posit
correl
express
cell
cycl
protein
includ
cyclin
cyclin
e
calcium
bind
protein
bind
involv
cancer
growth
invas
metastasi
protein
elev
melanoma
cell
propos
modul
activ
therebi
affect
melanoma
cell
growth
metastas
influenc
statu
also
correl
apoptosi
inhibitori
factor
melanoma
cell
express
bclxl
significantli
reduc
fa
death
domaincontain
protein
regul
program
cell
death
highli
express
melanoma
cell
protein
express
ratio
phosphoryl
ratio
decreas
melanoma
cell
lack
mice
melanoma
cell
enhanc
apoptosi
upregul
fa
downregul
bclxl
taken
togeth
statu
link
cell
prolifer
cellular
malign
possibl
ratio
mice
melanoma
cell
potenti
oncogen
found
sever
cancer
human
includ
breast
kidney
pancrea
prostat
cancer
inhibitor
differenti
dna
member
helixloophelix
transcript
factor
cellular
involv
delay
replic
senesc
inhibit
differenti
enhanc
prolifer
invas
immort
metastas
confer
chemotherapi
radiotherapi
resist
breast
colorect
esophag
lung
pancreat
cancer
elev
correl
poor
clinic
outcom
includ
shorter
surviv
resist
therapi
breast
cervic
nonsmal
cell
lung
cancer
knockdown
oxaliplatinresist
hepatocellular
carcinoma
hcc
cell
reduc
prolifer
induc
apoptosi
consist
vitro
find
silenc
reduc
size
growth
tumor
xenograft
nude
mice
tumor
lower
level
prolifer
higher
level
apoptosi
silenc
hcc
cell
result
decreas
activ
nadph
increas
ro
transfect
hcc
cell
revers
find
induc
oxaliplatin
resist
result
suggest
malign
chemoresist
hcc
cell
induc
mediat
activ
ppp
via
fact
silenc
hcc
cell
suppress
promot
activ
facilit
identif
cmyc
bind
site
promot
sequenc
oncogen
cmyc
essenti
regul
tumor
cell
cycl
progress
metabol
adapt
cmyc
regul
mani
gene
involv
energi
glucos
metabol
transfect
cmyc
rescu
defici
hcc
cell
pathway
analysi
indic
activ
cmyc
activ
cmyc
follow
transcript
therebi
switch
ppp
consequ
confer
hcc
cell
chemoresist
oxaliplatin
ampactiv
protein
kinas
ampk
ubiquit
eukaryot
heterotrimer
protein
complex
contain
protein
kinas
domain
subunit
glycogen
bind
domain
subunit
four
domain
subunit
main
function
ampk
monitor
intracellular
atp
fluctuat
balanc
atp
level
phosphoryl
downstream
substrat
ampk
regul
cell
growth
reprogram
metabol
transcript
interact
metabol
enzym
includ
acetylcoa
carboxylas
acc
hmgcoa
reductas
reprogram
energi
metabol
close
link
metastas
tumor
cell
metastas
reprogram
glycolysi
acid
environ
enhanc
angiogenesi
increas
carbon
flux
ppp
enhanc
tumor
cell
malign
aggress
attach
extracellular
matrix
ecm
critic
growth
differenti
normal
epitheli
cell
upon
detach
ecm
cell
undergo
apoptosi
known
anoiki
cancer
cell
need
adapt
absenc
ecm
circul
metastas
phenomenon
known
anchorageindepend
growth
process
multipl
survivalrel
cellular
molecular
chang
confer
anoiki
resist
cancer
cell
anchorageindepend
growth
found
human
breast
cancer
cell
compar
adher
breast
cancer
cell
detach
cell
display
elev
ro
suppress
increas
ro
level
suggest
regul
intracellular
ro
detach
breast
cancer
cell
compar
adher
breast
cancer
cell
reduc
glucos
uptak
lactic
acid
atp
indic
reduct
glycolysi
fatti
acid
oxid
fao
enzym
includ
phosphoacc
well
upregul
detach
cell
inhibit
newli
synthes
flavonoid
show
fao
glycolysi
main
sourc
atp
upon
detach
find
suggest
anoiki
detach
cell
shift
glycolysi
ppp
order
maintain
redox
homeostasi
fatti
acid
oxid
enhanc
support
atp
inhibit
anchorageindepend
growth
increas
ro
mechan
involv
disrupt
balanc
ppp
fao
induct
glycolipid
reprogram
activ
ampk
increas
pacc
downregul
mrna
protein
level
ampk
taken
togeth
ampk
activ
flavonoid
caus
decreas
ppp
fao
reprogram
increas
ro
result
inhibit
anchorageindepend
growth
breast
cancer
cell
tumor
suppressor
highli
mutat
gene
human
cancer
interact
regul
function
prevent
dimer
mutant
tumor
lack
activ
maintain
activ
import
regul
cellular
glucos
consumpt
biosynthesi
via
modul
suggest
protein
use
cancer
mutat
member
kinas
pak
serinethreonin
protein
kinas
role
pak
includ
cell
surviv
cytoskelet
reorgan
gene
transcript
cell
transform
overexpress
pak
commonli
found
cancer
group
ii
associ
tumorigenesi
progress
although
regul
glucos
metabol
known
glucos
metabol
regul
tumorigenesi
promot
lipid
biosynthesi
colon
cancer
cell
overexpress
colon
cancer
cell
enhanc
glucos
nadph
product
elev
activ
associ
overexpress
knockdown
reduc
activ
dhea
decreas
glucos
consumpt
nadph
find
indic
glucos
consumpt
nadph
product
mediat
enhanc
activ
close
relationship
support
fact
bind
complex
coloc
cytoplasm
downstream
protein
vitro
translat
bind
suggest
interact
silenc
enhanc
protein
express
indic
caus
degrad
ubiquitin
proteasom
pathway
modul
degrad
knockdown
impair
ubiquitin
murin
doubl
minut
antagonist
suppress
activ
two
mechan
inhibit
transcript
activ
direct
bind
enhanc
degrad
compon
ligas
interact
knockdown
reduc
level
facilit
bind
find
indic
enhanc
interact
caus
promot
ubiquitinmedi
degrad
absenc
fail
affect
glucos
consumpt
nadph
statu
colon
tissu
patient
colon
cancer
posit
correl
level
accord
fact
upregul
activ
histolog
score
show
elev
significantli
link
poor
patholog
tumornod
metastas
ptnm
die
cell
engag
revers
process
first
irrevers
phase
trespass
caspas
activ
complet
permeabil
mitochondri
outer
membran
exposur
phosphatidylserin
ps
send
eat
signal
neighbor
cell
concept
restrict
point
concern
cell
death
yet
specif
defin
differ
type
cell
death
may
occur
time
sever
type
cell
death
regul
cell
death
rcd
accident
cell
death
necroptosi
depend
differ
characterist
criteria
cell
readili
switch
one
type
cell
death
anoth
base
distinct
cellular
morpholog
three
major
type
cell
death
includ
type
apoptosi
type
ii
autophagi
type
iii
necrosi
downregul
impair
cellular
function
especi
regard
cell
surviv
major
function
mainten
cellular
redox
homeostasi
regener
nadph
defici
make
cell
suscept
stress
increas
oxid
damag
embryo
show
oxid
damag
establish
blood
circul
studi
indic
import
antioxid
function
growth
develop
apoptosi
extrins
apoptosi
common
cell
death
caus
inhibit
defici
enhanc
cellular
oxid
stress
apoptosi
inhibit
free
radic
scaveng
erythrocyt
predomin
enzym
product
nadph
oxid
damag
erythrocyt
suicid
known
eryptosi
caus
cell
shrinkag
membran
bleb
proteas
activ
phosphatidylserin
migrat
outer
membran
leaflet
nucleat
cell
inhibit
induc
apoptosi
suppress
cellular
prolifer
especi
cell
undergo
oxid
stress
increas
glucos
level
impair
activ
result
apoptosi
kidney
podocyt
mediat
ubiquitin
von
hippellindau
vhl
protein
subunit
ubiquitin
ligas
bind
undergo
ubiquitin
kidney
podocyt
ubiquitin
protein
degrad
ubiquitin
proteasom
pathway
cellular
redox
homeostasi
becom
unbalanc
increas
oxid
stress
autophagi
differ
program
cell
death
character
largescal
vacuol
cytoplasm
caspaseindepend
manner
autophagylysosom
pathway
major
pathway
remov
damag
macromolecul
organel
autophag
pathway
stimul
number
event
exposur
pathogen
oxid
stress
autophagi
modul
redox
homeostasi
glucos
metabol
statu
affect
autophagi
inhibit
polydatin
induc
endoplasm
reticulum
stress
deregul
autophagi
flux
cancer
cell
autophagosom
format
increas
polydatin
inhibit
synergist
increas
cytotox
effect
lapatinib
cancer
cell
abolish
upon
autophagi
inhibit
necrosi
prematur
cell
death
induc
injuri
includ
toxin
trauma
infect
cell
undergo
necrosi
show
swell
cell
membran
ruptur
expuls
cell
content
nearbi
cell
defici
predispos
cell
risk
viral
bacteri
infect
follow
necrot
cell
death
pretreat
antioxid
nacetylcystein
nac
confer
resist
infect
cell
netot
cell
death
anoth
form
cell
death
neutrophil
produc
neutrophil
extracellular
trap
net
consid
regul
form
necrosi
function
net
trap
bacteria
kill
protrud
filament
consist
fragment
chromatin
antimicrobi
peptid
netot
cell
death
regul
nox
activ
sever
defici
increas
suscept
infect
absenc
netot
cell
death
modul
statu
achiev
biochem
inhibitor
molecular
technolog
approach
discuss
section
well
list
tabl
noncod
rna
regul
direct
target
mrna
target
mrna
utr
tert
regul
inhibit
htert
decreas
express
proteinprotein
interact
directli
interact
dehydroepiandrosteron
dhea
adren
steroid
whose
biolog
role
fulli
understood
inhibit
dhea
potent
noncompetit
inhibitor
mammalian
decreas
cellular
nadph
level
nadphdepend
ro
product
detail
mechan
noncompetit
inhibit
respect
nadp
dhea
bind
enzymecoenzymesubstr
ternari
complex
dhea
wide
use
inhibitor
suppress
ppp
cancer
cell
structur
similar
nadp
inhibitor
dehydrogenas
competit
inhibitor
also
inhibit
oxidoreductas
turn
malic
enzym
reaction
polydatin
pd
also
name
piceid
natur
monocrystallin
compound
found
polygonum
cuspidatum
polygonacea
plant
grape
peanut
pd
glucosid
resveratrol
sever
biolog
effect
induct
apoptosi
cancer
cell
pd
inhibit
activ
stimul
gener
cellular
ro
increas
endoplasm
reticulum
stress
pd
caus
cell
cycl
arrest
phase
induc
apoptosi
inhibit
invas
current
specif
ppp
inhibitor
avail
clinic
trial
phase
ii
clinic
trial
show
pd
well
toler
human
also
limit
cancer
growth
metastat
spread
mice
model
oral
cancer
zoledron
acid
za
also
known
zoledron
current
standard
medic
use
treat
bone
diseas
bone
metastas
osteoporosi
za
inhibit
cell
prolifer
decreas
express
bladder
cancer
cell
stabil
activ
decreas
zatreat
bladder
cancer
cell
inhibit
ra
activ
suggest
za
inhibit
stabil
decreas
activ
via
block
ra
signal
bladder
cancer
cell
small
interf
rna
sirna
class
doublestrand
rna
molecul
base
pair
length
mediat
interfer
gene
express
complementari
nucleotid
sequenc
degrad
mrna
due
polymorph
target
gene
specif
sequenc
complementari
target
gene
need
care
consid
mani
studi
use
sirna
knockdown
investig
role
cell
line
human
gene
biochem
variant
worldwid
regard
genet
polymorph
need
consid
knock
express
genom
sequenc
encod
protein
length
exceed
nucleotid
usual
transcrib
long
noncod
rna
lncrna
lncrna
play
import
role
diseas
progress
growth
arrestspecif
transcript
lncrna
identifi
dysregul
cell
cycl
sever
cancer
melanoma
sampl
patient
show
significantli
reduc
express
advanc
diseas
larger
tumor
size
high
incid
metastas
knockdown
increas
melanoma
cell
prolifer
induc
cyclin
express
inhibit
apoptosi
via
increas
express
use
rna
coimmunoprecipit
reveal
interact
result
inhibit
nox
activ
lead
decreas
superoxid
nadp
data
suggest
could
regul
cellular
redox
balanc
directli
interact
microrna
mirna
small
noncod
rna
molecul
inhibit
gene
express
via
basepair
complementari
sequenc
within
mrna
molecul
belong
famili
involv
heart
diseas
myocardi
hypertrophi
infarct
high
concentr
glucos
lead
signific
upregul
cardiomyocyt
result
acceler
glucosemedi
apoptosi
cardiovascular
diseas
upregul
increas
cellular
oxid
stress
downregul
superoxid
dismutas
protein
express
involv
regul
express
target
utr
sequenc
indic
inhibit
high
glucos
concentr
may
due
upregul
anoth
mirna
candid
inhibit
liverspecif
mirna
decreas
express
directli
interact
utr
determin
luciferas
report
assay
ectop
express
decreas
express
hepatocellular
carcinoma
cell
cell
data
indic
regul
ppp
inhibit
telomeras
ribonucleoprotein
three
compon
includ
human
telomeras
rna
subunit
telomeraseassoci
protein
human
telomeras
revers
transcriptas
htert
main
function
insert
telomer
repeat
sequenc
end
telomer
mainten
telomer
support
longterm
cellular
growth
activ
telomeras
commonli
observ
stem
cell
human
cancer
glioma
cell
costunolid
treatment
inhibit
htert
activ
induc
cell
apoptosi
rosdepend
pathway
htert
inhibit
costunolid
molecular
technolog
sirna
dominantneg
htert
attenu
express
indic
possibl
role
loop
maintain
oxid
defens
respons
astrocyt
glial
cell
associ
athanogen
protein
involv
sever
cellular
function
autophagi
cell
cycl
regul
cellular
develop
pathogen
replic
addit
interact
atpas
domain
famili
also
contain
multipl
proteinbind
motif
interact
chaperon
hepatocellular
carcinoma
cell
model
protein
directli
interact
inhibit
dimer
activ
interact
decreas
ppp
flux
cell
growth
without
alter
cellular
nadph
protein
directli
bind
exert
tumor
suppressorlik
function
hcc
sever
inhibitor
induc
apoptosi
tumor
cell
noncod
rna
regul
rnabas
therapeut
might
reason
approach
cancer
therapi
although
success
preclin
studi
util
rnabas
therapi
proceed
clinic
trial
challeng
rnabas
therapeut
includ
offtarget
effect
target
gene
polymorph
ineffect
deliveri
system
site
interest
use
chemotherapi
variou
cancer
treatment
alway
associ
sever
nerv
damag
clinic
trial
dhea
unsuccess
need
high
oral
dose
convers
dhea
activ
form
although
pd
za
use
clinic
trial
treatment
irrit
bowel
syndrom
paget
diseas
bone
respect
detail
mechan
inhibit
pd
za
requir
elucid
sinc
biomark
inhibit
potenti
therapi
cancer
promis
seri
recent
develop
inhibitor
could
design
accord
interact
use
backbon
inhibitor
develop
novel
power
inhibitor
becom
import
issu
cancer
therapeut
comput
method
use
analyz
bind
structur
free
energi
design
potenti
dhea
deriv
establish
valuabl
insight
detail
enzymeinhibitor
bind
silico
find
provid
new
understand
possibl
design
potent
inhibitor
treatment
diseas
tumorigenesi
dynam
complex
process
state
tumor
develop
close
connect
dynam
chang
glucos
metabol
featur
cancer
cell
warburg
effect
character
fact
cancer
cell
favor
glycolysi
increas
lactat
product
even
presenc
oxygen
rather
oxid
phosphoryl
pathway
prefer
cell
bodi
metabol
switch
known
warburg
effect
respons
promot
synthesi
essenti
cellular
compon
rapidlyprolifer
cancer
cell
metabol
switch
affect
cancer
cell
immun
cell
macrophag
lymphocyt
myeloidderiv
suppressor
cell
mdsc
target
metabol
switch
metabolismregul
signal
pathway
tumor
develop
potenti
strategi
anticanc
treatment
combin
immunotherapi
metabol
switch
play
import
role
tumor
growth
includ
immun
escap
tumor
progress
resist
chemotherapi
activ
first
line
respons
oxid
stress
cancer
cell
cancer
cell
obtain
thorac
esophag
squamou
cell
carcinoma
patient
util
ppp
order
meet
need
rapid
growth
develop
resist
chemotherapi
oxid
posttransl
modif
alloster
interact
direct
result
inhibit
nadph
acut
stressinduc
glucos
rerout
may
explain
import
redoxsensit
metabol
requir
rapidli
prolifer
cell
bladder
cancer
cell
metabol
increas
express
fatti
acid
synthas
observ
favor
increas
metabol
glucos
ppp
increas
fattyacid
synthesi
ppp
hyperactiv
may
act
procarcinogen
bladder
cancer
cell
mitig
pathway
za
result
inhibit
lead
retard
bladder
cancer
cell
prolifer
indic
pathway
may
target
inhibit
metabol
analysi
acut
myeloid
leukemia
aml
cell
reveal
ppp
act
import
prosurviv
pathway
increas
activ
overexpress
correl
advers
prognosi
pinpoint
new
biomark
aml
determin
analysi
cancer
genom
atla
aml
databas
inhibit
induc
vitro
vivo
chemotherapeut
cytotox
aml
cell
demonstr
high
express
may
target
inhibit
unlik
cancer
cell
studi
metabol
switch
also
import
neuron
develop
involv
regul
neuron
surviv
especi
volatil
anestheticinduc
neuron
apoptosi
prolong
sevofluran
anesthesia
significantli
decreas
result
glucos
metabol
shift
ppp
neuron
glycolysi
lead
higher
suscept
oxid
stress
brain
indic
may
novel
target
glucos
metabol
reprogram
mutat
fmslike
tyrosin
kinas
often
observ
acut
myeloid
leukemia
aml
like
inhibitor
ultim
fail
achiev
longterm
remiss
ataxia
telangiectasia
mutat
atm
identifi
reason
resist
inhibitor
therapi
found
genomewid
rnaibas
screen
inactiv
atm
downstream
effector
sensit
aml
cell
inhibitorinduc
apoptosi
studi
indic
play
import
role
cancer
metabol
key
role
cancer
promot
cell
prolifer
antioxid
use
inhibitor
increas
cancer
cell
death
could
strategi
combin
cancer
therapi
radiotherapi
chemotherapi
immunotherapi
upregul
ppp
cancer
cell
make
potenti
target
cancer
therapi
major
characterist
cancer
cell
coordin
glucos
util
respons
cell
physiolog
reprogram
glucos
metabol
rerout
glucos
ppp
produc
high
level
nadph
counteract
ro
provid
nucleotid
dna
synthesi
activ
confer
resist
elev
ro
dna
damag
increas
ppp
activ
induc
high
level
ro
counteract
adapt
respons
found
use
chemotherapeut
agent
radiat
oxid
agent
drugresist
cancer
cell
line
display
increas
activ
increas
intracellular
glutathion
concentr
indic
oxid
ppp
enhanc
nonoxid
ppp
link
resist
dnadamag
drug
like
elev
tkt
detect
colon
cancer
cell
although
increas
ppp
weapon
use
drugresist
cancer
cell
modul
ppp
statu
serv
strategi
sensit
cancer
cell
therapi
doxorubicin
member
anthracyclin
use
chemotherapi
metabol
cytochrom
caus
cytotox
produc
ro
reduc
activ
found
doxorubicinresist
breast
cancer
cell
stimul
ppp
may
sensit
cancer
cell
doxorubicin
treatment
breast
cancer
cell
line
larginin
combin
enhanc
apoptosi
decreas
metastas
target
cytotox
acut
myeloid
leukemia
cell
sensit
cell
chemotherapi
inhibit
breast
cancer
cell
synergist
enhanc
tyrosin
kinas
inhibitorinduc
cytotox
effect
metabolismbas
therapeut
strategi
might
solut
imped
rapid
growth
metastas
well
cancer
cell
heterogen
cancer
stem
cell
activ
local
regul
sever
protein
includ
stat
hgf
ampk
disrupt
interact
protein
inhibit
reprogram
glucos
toward
ppp
impair
biosynthesi
build
block
cancer
cell
associ
decreas
intracellular
nadph
anoth
potenti
therapeut
strategi
thwart
rapidli
grow
cancer
cell
main
function
provid
suffici
reduc
power
support
growth
maintain
redox
homeostasi
studi
regard
defici
tradit
focus
red
cell
disord
current
studi
nucleat
cell
reveal
particip
varieti
cellular
process
via
redox
signal
close
relationship
exist
nadph
reactiv
speci
particular
nox
no
two
major
nadphdepend
enzym
gener
reactiv
speci
involv
cellular
signal
alter
redox
homeostasi
cell
lead
impair
antioxid
defens
cellular
signal
defici
associ
myriad
patholog
event
diseas
critic
signal
govern
cell
growth
cell
death
aberr
activ
link
tumorigenesi
malign
rapidli
grow
cancer
cell
rais
possibl
whether
serv
therapeut
target
concomit
exist
anticanc
drug
tackl
cancer
resist
approach
chemic
molecular
inhibitor
use
wide
novel
method
inhibit
action
modul
metabol
switch
redox
homeostasi
proteinprotein
interact
great
interest
thwart
rapid
growth
metastasi
heterogen
cancer
cell
